Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;26(1):225-258.
doi: 10.1007/s00784-021-03995-5. Epub 2021 May 29.

Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment

Talita Mendes Oliveira Ventura  1 , Nathalia Regina Ribeiro  1 , Even Akemi Taira  1 , Aline de Lima Leite  1 , Aline Dionizio  1 , Cássia Maria Fischer Rubira  2 , Paulo Sérgio da Silva Santos  2 , Marília Afonso Rabelo Buzalaf  3
Affiliations

Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment

Talita Mendes Oliveira Ventura et al. Clin Oral Investig. 2022 Jan.

Abstract

Objectives: Salivary glands are affected during radiotherapy in the head and neck region, leading to a reduction in salivary flow and changes its composition. Besides negatively affecting the oral soft tissues, this can also lead to dental impairment. Thus, we evaluated the effect of radiotherapy in the proteomic profile of the saliva in patients with head and neck cancer (HNC).

Materials and methods: HNC patients had their saliva collected before (BRT), during (2-5 weeks; DRT), and after (3-4 months; ART) radiotherapy. Saliva was also collected from healthy volunteers (control; C). Samples were processed for proteomic analysis.

Results: In total, 1055 proteins were identified, among which 46 were common to all groups, while 86, 86, 286, and 395 were exclusively found in C, BRT, DRT, and ART, respectively. Remarkably, alpha-enolase was increased 35-fold DRT compared with BRT, while proline-rich proteins were decreased. ART there was a 16-fold increase in scaffold attachment factor-B1 and a 3-fold decrease in alpha-enolase and several cystatins. When compared with C, salivary proteins of BRT patients showed increases cystatin-C, lysozyme C, histatin-1, and proline-rich proteins CONCLUSION/CLINICAL REVELANCE: Both HNC and radiotherapy remarkably change the salivary protein composition. Altogether, our results, for the first time, suggest investigating alpha-enolase levels in saliva DRT in future studies as a possible biomarker and strategy to predict the efficiency of the treatment. Moreover, our data provide important insights for designing dental products that are more effective for these patients and contribute to a better understanding of the progressive changes in salivary proteins induced by radiotherapy. Graphical abstract.

Keywords: Biomarkes; Dental caries; Head and neck cancer; Proteomics; Radiotherapy; Saliva.

PubMed Disclaimer

References

    1. Safdari Y, Khalili M, Farajnia S, Asgharzadeh M, Yazdani Y, Sadeghi M (2014) Recent advances in head and neck squamous cell carcinoma--a review. Clin Biochem 47(13-14):1195–1202. https://doi.org/10.1016/j.clinbiochem.2014.05.066 - DOI - PubMed
    1. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9–22. https://doi.org/10.1038/nrc2982 - DOI - PubMed
    1. Cruz FO, Ferreira EB, Vasques CI, Mata LR, Reis PE (2016) Validation of an educative manual for patients with head and neck cancer submitted to radiation therapy. Rev Lat Am Enfermagem:24. https://doi.org/10.1590/1518-8345.0949.2706
    1. Soulieres D, Faivre S, Mesia R, Remenar E, Li SH, Karpenko A, Dechaphunkul A, Ochsenreither S, Kiss LA, Lin JC, Nagarkar R, Tamas L, Kim SB, Erfan J, Alyasova A, Kasper S, Barone C, Turri S, Chakravartty A, Chol M, Aimone P, Hirawat S, Licitra L (2017) Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncol 18:323–335. https://doi.org/10.1016/S1470-2045(17)30064-5 - DOI - PubMed
    1. Zago SD (2006) The radiotherapy effect on the quality of life of patients with head and neck cancer. Revista Brasileira de Cancerologia 52(4):323–329 - DOI

LinkOut - more resources